p53 alterations in breast cancer of the Parsi ethnic group

被引:0
|
作者
Abbas, A [1 ]
Kukreti, R [1 ]
Naik, S [1 ]
Therwath, A [1 ]
机构
[1] UNIV PARIS 07,MOL ONCOL LAB,F-75005 PARIS,FRANCE
关键词
breast cancer; SSCP; p53; mutations;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Mutations in p53 are the most common genetic abnormality yet found in human cancers. p53 mutations vary among tumor types, ranging from 0-60% in major cancers. The frequency of p53 mutations in breast cancer averages around 25%. The incidence rate and the type of mutations at specific codons seem to be influenced by geographical location as well as racial and ethnic specificities. Women of the Parsi ethnic group living mostly in defined geographical areas around metropolitan Bombay are reported to have a markedly high incidence of breast cancer. In the present work, the p53 gene alterations in the Parsis were investigated using SSCP analysis. The results confirm an earlier observation that over 60% of the Parsi breast tumors harbour p53 alterations. This figure is higher than that observed in other communities. The relevance of the finding in the light of the high breast cancer incidence in the Parsis is discussed.
引用
收藏
页码:401 / 404
页数:4
相关论文
共 50 条
  • [21] Loss of hMSH2 expression in primary breast cancer with p53 alterations
    Spagnoletti, I
    Pizzi, C
    Galietta, A
    Di Maio, M
    Mastranzo, P
    Daniele, S
    Limite, G
    Pettinato, G
    Contegiacomo, A
    ONCOLOGY REPORTS, 2004, 11 (04) : 845 - 851
  • [22] RACIAL DISPARITY IN THE ASSOCIATION OF P53 GENE ALTERATIONS WITH BREAST-CANCER SURVIVAL
    SHIAO, YH
    CHEN, VW
    SCHEER, WD
    WU, XC
    CORREA, P
    CANCER RESEARCH, 1995, 55 (07) : 1485 - 1490
  • [23] p53 alterations and protein accumulation in benign breast tissue and breast cancer risk: A cohort study
    Rohan, Thomas E.
    Li, Shu-Qiu
    Hartwick, Robert
    Kandel, Rita A.
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (07) : 1316 - 1323
  • [24] Role of p53 in breast cancer progression: An insight into p53 targeted therapy
    Marvalim, Charlie
    Datta, Arpita
    Lee, Soo Chin
    THERANOSTICS, 2023, 13 (04): : 1421 - 1442
  • [25] The p53/miRNA Axis in Breast Cancer
    Hosseini, Reza Shah
    Nouri, Seyed Mohammad
    Bansal, Pooja
    Hijazi, Ahmed
    Kaur, Harpreet
    Kareem, Anaheed Hussein
    Kumar, Abhinav
    Al Zuhairi, Rafil Adnan Hussein
    AL-Shaheri, Nadhim Allawi
    Mahdavi, Parya
    DNA AND CELL BIOLOGY, 2024, 43 (11) : 549 - 558
  • [26] EXPRESSION OF SURVIVIN AND p53 IN BREAST CANCER
    Dwijendra, Nath
    Pallavi, Agrawal
    Arun, Singh
    Niharika, Rawat
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2018, 7 (07): : 881 - 885
  • [27] p53 in breast cancer: mutation and countermeasures
    Kumar, Sumit
    Walia, Vijay
    Ray, Maria
    Elble, Randolph C.
    FRONTIERS IN BIOSCIENCE-LANDMARK, 2007, 12 : 4168 - 4178
  • [28] p53 polymorphisms and haplotypes in breast cancer
    Sjalander, A
    Birgander, R
    Hallmans, G
    Cajander, S
    Lenner, P
    Athlin, L
    Beckman, G
    Beckman, L
    CARCINOGENESIS, 1996, 17 (06) : 1313 - 1316
  • [29] p53 haplotype determination in breast cancer
    Weston, A
    Pan, CF
    Ksieski, HB
    Wallenstein, S
    Berkowitz, GS
    Tartter, PI
    Bleiweiss, IJ
    Brower, ST
    Senie, TR
    Wolff, MS
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (02) : 105 - 112
  • [30] Overexpression of p53 in human breast cancer
    Minguillon, C
    Heinze, T
    Schönborn, I
    Lichtenegger, W
    JOURNAL OF TUMOR MARKER ONCOLOGY, 1999, 14 (01): : 13 - 17